INSIGHTS ON DRUG DEVELOPMENT
-
Thunderstruck By Antibody-Drug Conjugates
Antibody-drug conjugates are transforming cancer treatment by targeting tumors directly to reduce side effects. Discover how they affect neighboring cells, which can enhance treatment efficacy and eliminate tumor cell populations.
-
Integrating High-Content Imaging With Traditional Plate-Based Screening
Gain mechanistic insights beyond traditional viability assays, revealing nuanced cellular phenotypes and strengthening early drug discovery decisions without sacrificing throughput or efficiency.
-
The People Who Turn An Idea Into A Deliverable Product
Drug developers and device engineers share more common ground than their distinct disciplines suggest, facing parallel pressures around design, safety, regulatory approval, and scalable performance.
-
Overcoming Gene Therapy Cost Roadblocks On The Path To Patients
Viral vector-based gene therapies are expanding beyond rare diseases to treat larger populations. Discover how innovations in manufacturing are making these life-changing treatments more accessible.
-
Expanding The OSD Toolbox: An Industry Approach To Adsorb Lipids Onto Powder Substrates12/11/2024
Explore innovative solutions for improving the solubility and bioavailability of poorly soluble compounds in solid oral dosage forms to enhance drug delivery and therapeutic effectiveness.
-
Label-Free Analysis Of Multiple Spheroids In A Matrix11/7/2025
Gain insight into how automated z-stack imaging and AI-based analysis enable accurate, label-free monitoring of spheroid development in 3D matrices for drug screening and cell culture workflows.
-
Comprehensive And Streamlined Genomic Signature Assessment6/9/2026
Simultaneous analysis of HRD, TMB, and MSI offers a more complete view of tumor biology. A modular sequencing approach enables efficient workflows, conserves samples, and delivers deeper insights.
-
Advancing Cell Culture Strategies To Accelerate Biologics Development5/5/2026
Integrated stable expression strategies accelerate biologics material generation, improving scalability, consistency, and early developability insights while reducing bottlenecks, variability, and risks in transitioning from discovery to manufacturing.
-
Streamline Your Workflow With An Innovative Fixed-Bed System11/4/2025
Discover how an innovative fixed-bed system streamlines workflows and supports consistent, high-yield manufacturing across a range of applications.
DRUG DEVELOPMENT SOLUTIONS
-
Orbis provides innovative taste-making and controlled release solutions for oral and injectable pharmaceutical products.
-
12 MP Microscope Camera Flexacam C3
Save time when capturing, documenting, and sharing images with the Flexacam C3 microscope camera. It transforms your microscope into a stand-alone digital imaging station without the need for a PC.
Make reliable and accurate decisions for your application tasks with powerful color accuracy. True-to-life colors and fine details are a given thanks to the 12 MP CMOS sensor, large dynamic range, and fast signal processing.
Collaborate in real time and review images efficiently as a team by taking advantage of the fast display of live images.
-
Uniquely Ergonomic System Microscope Leica DM1000
The ergonomically designed Leica DM1000 with adjustable features and easy-to-use controls adapts to every user to improve comfort and convenience while working at the microscope.
Featuring high-quality optical performance, the Leica DM1000 is ideal for all clinical laboratory applications, in particular cytology, haematology, and pathology. For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) like in-vitro-fertilization (IVF).
Its advanced capabilities, including fluorescence, make it well suited also for complex tasks.
-
Use a real-time PCR (qPCR) solution for testing cell therapy products that provides sterility results in less than 5 hours.
-
With extensive experience in handling challenging chemistries and complex synthetic processes, we deliver tailored solutions designed to support successful progression from preclinical studies to market.